首页> 外国专利> KITS OF HYDRALAZINE COMPOUNDS AND ISOSORBIDE DINITRATE AND/OR ISOSORBIDE MONONITRATE

KITS OF HYDRALAZINE COMPOUNDS AND ISOSORBIDE DINITRATE AND/OR ISOSORBIDE MONONITRATE

机译:肼化合物和硝酸异烟酯和/或单硝酸异烟酯的试剂盒

摘要

The present invention provides methods of treating and preventing mortality associated with heart failure in an African American patient with hypertension and improving oxygen consumption, quality of life and exercise tolerance by administering a therapeutically effective amount of at least one hydralazine compound and at least one of isosorbide dinitrate and isosorbide mononitrate, and, optionally, one or more compounds, such as, for example, a digitalis, a diuretic compound, or a compound used to treat cardiovascular diseases. In the present invention, the hydralazine compound is preferably hydralazine or a pharmaceutically acceptable salt thereof. Preferred methods of the invention comprise administering hydralazine or a pharmaceutically acceptable salt thereof and isosorbide dinitrate.
机译:本发明提供了通过给予治疗有效量的至少一种肼苯哒嗪化合物和异山梨醇中的至少一种来治疗和预防非洲裔美国人高血压患者与心力衰竭相关的死亡率并改善耗氧量,生活质量和运动耐受性的方法。硝酸盐和异山梨醇一硝酸盐,以及任选地一种或多种化合物,例如洋地黄,利尿剂化合物或用于治疗心血管疾病的化合物。在本发明中,肼苯哒嗪化合物优选为肼苯哒嗪或其药学上可接受的盐。本发明的优选方法包括施用肼屈嗪或其药学上可接受的盐和硝酸异山梨酯。

著录项

  • 公开/公告号US2008226752A1

    专利类型

  • 公开/公告日2008-09-18

    原文格式PDF

  • 申请/专利权人 JAY N. COHN;PETER CARSON;

    申请/专利号US20080053346

  • 发明设计人 JAY N. COHN;PETER CARSON;

    申请日2008-03-21

  • 分类号A61K33;A61K31/502;A61K31/55;A61K31/351;A61K31/403;A61K31/4422;A61K31/4178;A61K31/506;A61K31/40;A61P9/10;

  • 国家 US

  • 入库时间 2022-08-21 20:15:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号